论文信息 - A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma - 字舞流文

A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma

J. H. Lee | Y. Won | S. Kim | H. Kang | Jin Seok Kim | H. Eom | C. Suh | W. Kim | J. Jo | Y. Do | S. Oh | D. Yoon | W. Lee | Hyewon Lee | J. Yi | J. Hong | Myungsook Chang | Kyoungha Kim | J. Won | I. Kim | I. Kim | Inho Kim